We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Safety and Pharmacokinetics of Orally Administered Gallium Maltolate in Various Refractory Malignancies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00050687
Recruitment Status : Terminated
First Posted : December 19, 2002
Last Update Posted : January 28, 2011
Information provided by:
Titan Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : March 2005
  Study Completion Date : March 2005
  Certification or Request for Extension to Delay Results Submission: January 11, 2011